ER β exerts multiple stimulative effects on human breast carcinoma cells

Yi-Feng Hou,Sheng-Tao Yuan,He-Cheng Li,Jiong Wu,Jin-Song Lu,Gang Liu,Li-Juan Lu,Zhen-Zhou Shen,Jian Ding,Zhi-Ming Shao

DOI: https://doi.org/10.1038/sj.onc.1207765

IF: 8.756

2004-01-01

Oncogene

Abstract:Recent studies of ERs in breast cancer have demonstrated the existence of ER β in addition to ER α . Some clinical data indicated that ER β had prognostic value for patient's survival, which suggested that ER β plays a key role in breast cancer development and metastasis. To test this hypothesis, we generated an ER β high-expression cell line by reintroduced human ER β cDNA into MDA-MB-435 cells. We demonstrated that ER β exerted multiple tumor-stimulative effects on human breast carcinoma cells both in vivo and in vitro . In in vitro studies, ER β was able to increase the proliferation and invasion of MDA-MB-435 cells significantly, while these effects were totally estradiol independent. Also, this stimulation was characterized by downregulation of p21 and upregulation of MMP-9, as well as transcriptional factor Est-1. In in vivo studies, we also demonstrated that ER β -transfected MDA-MB-435 cells grew much faster and had more pulmonary metastasis than mock or wild-type cells in nude mice. In ER β -transfected MDA-MB-435 xenografts, ER β caused significant reduction in p21 protein levels. Similar effects of ER β on MMP-9 and Ets-1 expression noted in vitro studies were also observed in the in vivo studies. These in vitro and in vivo studies indicated that ER β exerted multiple stimulative effects on breast cancer development and metastasis.